Highlights from the issue
Caption
Inside Virginia’s Rise to Biopharma Prominence
A look at the partnerships and targeted investment that created the next U.S. biopharma hotspot — and the work that still needs to be done
Dulles Prepares for Pharma Growth Through Brussels Partnership
Trans-Atlantic super-corridor will serve biopharma manufacturing hotspots in Belgium, Virginia
Enabling Innovation
Across Virginia, local life sciences ecosystems are helping researchers connect with the funding and facilities they need to grow
We have great talent, which attracts companies like Lilly, Merck, and AstraZeneca, which attracts other companies to become part of the ecosystem, which thus attracts more talent because not only do the companies see there's something cool happening in Virginia, the talent also sees it.
Selected Virginia Wins
Podcast
Hear it from
thought leaders
Virginia really surprised us on how fast the government can move — the rapid decision-making, motivation, and sense of urgency to do everything you guys can to build a better future with innovative medicine for the local community, and in this case, for American people.
Virginia [is] such an important part of the future of the biopharmaceutical ecosystem. You can see that in not only the attractiveness for Merck to continue with our investment, but also some of the additional investments coming into this state now.
Regional spotlight:
Greater Richmond
Regional spotlight:
The I95-I85 Intersection
Past issues
Virginia: Investing in its talent and workforce
This issue of Virginia Economic Review takes an in-depth look at Virginia’s talent infrastructure and the ways the Commonwealth invests in its workforce.
Where goods, information and people converge
This issue takes an in-depth look at Virginia’s infrastructure and the investments the Commonwealth makes to improve it.
The livability issue
This issue celebrates all of the unique factors that contribute to Virginia’s unbeatable quality of life.